Results show that NASH patients have higher levels of CK-18 fragments, which were closely correlated with steatosis severity, ballooning, lobular inflammation, and fibrosis stage in the NAFLD patients. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.